Life Science Analytics

Life Science Analytics, Inc. (LSA), is a biomedical data company that provides comprehensive pipeline and financial information on nearly 10,000 biomedical companies worldwide. Our data and research products serve executives in the pharmaceutical, biotech, and financial industries. LSA products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes.

Results 1 - 20 of 4592

previous 1 2 3 4 5 6 7 8 9 10 11 next

last

Title	Date	Price
Synergy Healthcare Limited-Company Report	Sep 2009	£460
Ecobi Farmaceutici s.a.s.-Company Report	Sep 2009	£455
Dr. F. Frik Ilac San. Ve Tic. A. S.-Company Report	Sep 2009	£455
Dr. R. Pfleger Chemische Fabrik GmbH-Company Report	Sep 2009	£455
Synerx Pharma-Company Report	Sep 2009	£460
Taejoon Pharma Co., Ltd.-Company Report	Sep 2009	£460
TCA Cellular Therapy, LLC-Company Report	Sep 2009	£455
Tasly Group-Company Report	Sep 2009	£455
Taiwan Biotech Co., Ltd.-Company Report	Sep 2009	£455
Eagle Pharmaceuticals Pty Ltd-Company Report	Sep 2009	£455
DoNatur GmbH-Company Report	Sep 2009	£455
Ecopharm-Company Report	Sep 2009	£455
Eiger BioPharmaceuticals, Inc.-Company Report	Sep 2009	£455
EluSys Therapeutics, Inc.-Company Report	Sep 2009	£455
CytoCore, Inc.-Deals & Alliances Report	Sep 2009	£360
Danaher Corp.-Deals & Alliances Report	Sep 2009	£360
The Dow Chemical Company-Deals & Alliances Report	Sep 2009	£365
Depomed Inc-Therapeutic Competitors	Sep 2009	£210
Quest Diagnostics Inc.-Deals & Alliances Report	Sep 2009	£360
Star Drugs and Research Labs Ltd.-Company Report	Sep 2009	£455